StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Mirum Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Mirum Pharmaceuticals's total assets was $1.04B at Jun 30, 2026. For fiscal 2025 it was $842.81M, up 25.7% from the year before. The highest annual figure on record is $842.81M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$842.81M+25.7%
FY2024Dec 31, 2024$670.75M+3.7%
FY2023Dec 31, 2023$646.62M+83.2%
FY2022Dec 31, 2022$352.91M+19.8%
FY2021Dec 31, 2021$294.65M+22.3%
FY2020Dec 31, 2020$240.86M+64.2%
FY2019Dec 31, 2019$146.71M+182.3%
FY2018Dec 31, 2018$51.98M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.04B+44.0%
Q1 FY2026Mar 31, 2026$890.92M+29.1%
Q4 FY2025Dec 31, 2025$842.81M+25.7%
Q3 FY2025Sep 30, 2025$785.12M+17.6%
Q2 FY2025Jun 30, 2025$725.83M+9.8%
Q1 FY2025Mar 31, 2025$690.25M+5.9%
Q4 FY2024Dec 31, 2024$670.75M+3.7%
Q3 FY2024Sep 30, 2024$667.89M+2.7%
Q2 FY2024Jun 30, 2024$660.75M+49.0%
Q1 FY2024Mar 31, 2024$651.96M+84.7%
Q4 FY2023Dec 31, 2023$646.62M+77.5%
Q3 FY2023Sep 30, 2023$650.64M+118.9%
Q2 FY2023Jun 30, 2023$443.59M+59.5%
Q4 FY2022Dec 31, 2022$352.91M+19.8%
Q3 FY2022Sep 30, 2022$364.35M+54.9%
Q2 FY2022Jun 30, 2022$297.23M+20.0%
Q1 FY2022Mar 31, 2022$278.15M+25.2%
Q4 FY2021Dec 31, 2021$294.65M+22.3%
Q3 FY2021Sep 30, 2021$235.17M+65.8%
Q2 FY2021Jun 30, 2021$247.67M+59.0%
Q1 FY2021Mar 31, 2021$222.24M+28.6%
Q4 FY2020Dec 31, 2020$240.86M+64.2%
Q3 FY2020Sep 30, 2020$141.87M-10.4%
Q2 FY2020Jun 30, 2020$155.77M+49.4%
Q1 FY2020Mar 31, 2020$172.80M+232.5%
Q4 FY2019Dec 31, 2019$146.71M–
Q3 FY2019Sep 30, 2019$158.27M–
Q2 FY2019Jun 30, 2019$104.27M–
Q4 FY2018Dec 31, 2018$51.98M–

More Mirum Pharmaceuticals figures

See a number that looks wrong?